These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Priorities in renal replacement programs. Bonomini V Int J Artif Organs; 2002 May; 25(5):397-400. PubMed ID: 12074337 [TBL] [Abstract][Full Text] [Related]
5. Moving ahead on the Kidney Health Initiative innovation roadmap, a transatlantic progress update. Wieringa FP; Sheldon M; Ash SR; Groth T; Boomker J; Oostrom T; Vanholder R Artif Organs; 2020 Nov; 44(11):1125-1134. PubMed ID: 32969045 [No Abstract] [Full Text] [Related]
6. Dispelling the myths of providing dialysis in low- and middle-income countries. Teerawattananon Y; Tungsanga K; Hakiba S; Dabak S Nat Rev Nephrol; 2021 Jan; 17(1):11-12. PubMed ID: 32814894 [TBL] [Abstract][Full Text] [Related]
7. Renal replacement therapy in acute kidney injury: an overview. Kanagasundaram NS Br J Hosp Med (Lond); 2007 Jun; 68(6):292-7. PubMed ID: 17639824 [No Abstract] [Full Text] [Related]
8. Advances in Machine Technology. Clark WR; Villa G; Neri M; Ronco C Contrib Nephrol; 2018; 194():80-89. PubMed ID: 29597219 [TBL] [Abstract][Full Text] [Related]
9. Using Patient Preference Information to Inform Regulatory Decision Making: An Opportunity to Spur Patient-Centered Innovation in Kidney Replacement Therapy Devices. Flythe JE; West M Clin J Am Soc Nephrol; 2021 Apr; 16(4):642-644. PubMed ID: 33658178 [No Abstract] [Full Text] [Related]
13. Probing expert opinions on the future of kidney replacement therapies. Pereira Cabral B; Bonventre JV; Wieringa F; Mota FB Artif Organs; 2021 Jan; 45(1):79-87. PubMed ID: 32697860 [TBL] [Abstract][Full Text] [Related]
14. [The wearable artificial kidney: a promise for the future?]. Wester M; Gerritsen KG; Boer WH; Joles JA; Kooman JP Ned Tijdschr Geneeskd; 2013; 157(52):A6965. PubMed ID: 24382046 [TBL] [Abstract][Full Text] [Related]
15. The long road to wearable blood-cleansing devices. Kooman JP; van der Sande FM; Leunissen KM Blood Purif; 2007; 25(4):377-82. PubMed ID: 17785967 [No Abstract] [Full Text] [Related]
17. A Continuous Renal Replacement Therapy Protocol on the Updated Nikkiso Aquarius Platform Using Regional Citrate as First-Line Anticoagulation Significantly Improves Filter Life Span but the Position of the Vascular Access is Key. Kirwan CJ; Jackson L; Prowle JR Blood Purif; 2018; 45(1-3):129-130. PubMed ID: 29402829 [No Abstract] [Full Text] [Related]